| 期刊論文1. | Adams, M., Jasani, B.,、Fiander, A.(2007)。Human papilloma virus (HPV) prophylactic vaccination: Challenges for public health and imply-cation for screening。Vaccine,25(16),3007-3013。 | 2. | Cadman, L.(2006)。Know the fact。Nursing Standards,21(9),17。 | 3. | Frazer, I. H.,、Cox, J.(2006)。Finding a vaccine for human papillomavirus。Lancet,367(9528),2058-2059。 | 4. | Giles, M.,、Garland, S.(2006)。A study of women’s knowledge regarding human papillomavirus vaccines。Australian and New Zealand Journal of Obstetrics and Gynaecology,46(4),311-315。 | 5. | Muno, N., Bosch, F. X., Sanjose, S., Herrero, R. Castellsaque, S. Shah, K. V., et al.(2003)。Epidemiologic classification of human papillomavirus types associated with cervical cancer。New England Journal of Medicine,348(6),518-27。 | 6. | Nakagawa, M., Viscidi, R., Deshmukh, I., Costa, M. D., Palefsky, J. M., Farhat, S., et al.(2002)。Time course of humoral and cell-mediated immune responses to human papillomavirus type 16 in Infected women。Clinical and Diagnostic Laboratory Immunology,9(4),877-82。 | 7. | Tyring, S. K.(2000)。Human papillomavirus infection:epidemiology, path-ogenesis, and host immune responses。Journal of American Academy of Dermatology,43(1pt2),S18-26。 | 會議論文1. | Chen, H. C., Lin, C. Y.,、Pan, M. H.(2006)。HPV type-specific prevalence and co-infection rate among 10602 women in Taiwan. Communitybased cancer screening project (CBCSP) in Taiwan, the CBCSP cohort study。Taiwan: Taipei。 | |